99mtc-glycopeptide

99mTc-glycopeptide is a **radiopharmaceutical** compound in which the radioisotope technetium-99m (99mTc) is attached to a glycopeptide molecule. The addition of the glycopeptide provides tissue targeting and biodistribution properties specific to the peptide construct, while 99mTc enables **non-invasive nuclear imaging** through gamma ray emission. Like other technetium-99m radiopharmaceuticals, the primary mechanism of action is gamma photon emission after tissue localization, which enables diagnostic imaging via SPECT (single-photon emission computed tomography). The glycopeptide moiety allows for potential targeting of specific tissues or pathological sites based on the peptide structure. The compound is typically synthesized on-site due to the short half-life of technetium-99m and is used to visualize tissue distribution, function, or disease process. Clinical use and developer/manufacturer information for this specific agent remains limited; however, technetium-99m radiopharmaceuticals in general are widely used in organ imaging such as bone, renal, cardiac, hepatobiliary, neuroendocrine, and oncological applications[1][2][3][5][6].

Other names

technetium-99m-glycopeptidetechnetium99m-glycopeptidetechnetium 99m-glycopeptideTc-99m-glycopeptideTc99m-glycopeptideTc 99m-glycopeptide